CDIO 8-K — Smart Summary

Cardio Diagnostics Holdings, Inc. announced on May 28, 2025 that it has regained compliance with Nasdaq's minimum bid price requirement after the closing bid price of its common stock was $1.00 per share or greater for 10 consecutive business days from May 13, 2025 through May 27, 2025.

• On June 3, 2024, the Company received a Nasdaq written notification that its common stock closing bid price had been below $1.00 per share for 30 consecutive business days, triggering non-compliance with Nasdaq Listing Rule 5550(a)(2).
• The Company was initially given 180 calendar days, until December 2, 2024, to regain compliance.
• In a letter dated December 4, 2024, Nasdaq granted an additional 180 calendar day period, extending the compliance deadline to June 2, 2025.
• On May 28, 2025, Nasdaq's Listing Qualifications Staff notified the Company that it had regained compliance, as the closing bid price was $1.00 per share or greater for the 10 consecutive business days from May 13, 2025 through May 27, 2025.